Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia

被引：0
|
作者：
Marder, S.
Comella, C.
Singer, C.
Chepke, C.
Burke, J.
Farahmand, K.
Siegert, S.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1464
引用
收藏
页码：S598 / S598
页数：1
相关论文
共 50 条
  • [1] LONG-TERM TREATMENT WITH VALBENAZINE 40 MG ONCE-DAILY IN ADULTS WITH TARDIVE DYSKINESIA
    Chepke, C.
    Marder, S. R.
    Comella, C. L.
    Singer, C.
    Farahmand, K.
    Shah, C.
    Lundt, L.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E119 - E120
  • [2] Long-Term Effects of Valbenazine on Tardive Dyskinesia in Older and Younger Adults
    Alexopoulos, George S.
    Sajatovic, Martha
    Sheth, Bijal
    Siegert, Scott
    Farahmand, Khodayar
    Burke, Joshua
    Liang, Grace S.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S158 - S159
  • [3] Long-Term Safety and Tolerability of Valbenazine in Older and Younger Adults with Tardive Dyskinesia
    Sajatovic, Martha
    Alexopoulos, George S.
    Guillory, Monica
    Farahmand, Khodayar
    Burke, Joshua
    Liang, Grace S.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S159 - S160
  • [4] Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Singer, Carlos
    Comella, Cynthia
    Marder, Stephen
    Farahmand, Khodayar
    Jimenez, Roland
    [J]. NEUROLOGY, 2020, 94 (15)
  • [5] Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine
    Factor, S.
    Comella, C.
    Marder, S.
    Burke, J.
    Farahmand, K.
    Siegert, S.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S595 - S596
  • [6] Effects of Concomitant Medication Use on Tardive Dyskinesia Outcomes in Long-Term Valbenazine Trials
    Comella, Cynthia
    Singer, Carlos
    Kane, John
    Farahmand, Khodayar
    Burke, Joshua
    Siegert, Scott
    [J]. NEUROLOGY, 2019, 92 (15)
  • [7] LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA
    Harrigan, K.
    Walton, S. M.
    Huang, S. P.
    Kumar, V. M.
    Chapman, R. H.
    Atlas, S. J.
    Agboola, F. O.
    Ollendorf, D. A.
    Touchette, D. R.
    [J]. VALUE IN HEALTH, 2018, 21 : S184 - S184
  • [8] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (01) : 3 - 3
  • [9] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. CNS SPECTRUMS, 2023, 28 (02) : 241 - 241
  • [10] A long-term, open-label study of valbenazine for tardive dyskinesia
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Marder, Stephen R.
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace S.
    O'Brien, Christopher F.
    [J]. CNS SPECTRUMS, 2021, 26 (04) : 345 - 353
12345